Announcements

We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

Richard DiMarchi Indiana University, USA	Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed.
“Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee
Rolf Müller Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany; Helmholtz Centre for Infections Research (HZI), Germany; Saarland University, Germany	Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature.
“The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.” —Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee

The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.

2024 Award Committee
Committee Chair:

• Prof. Dr. A. Douglas Kinghorn, Ohio State University, USA.
  

Committee Members (listed in alphabetical order):

• Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
• Prof. Binghe Wang, Georgia State University, USA;
• Dr. Diana Pinto, University of Aveiro, Portugal;
• Prof. Hideaki Kakeya, Kyoto University, Japan;
• Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
• Prof. Thomas Prisinzano, University of Kentucky, USA
• Prof. Wei Li, University of Tennessee Health Science Center, USA.

About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Six new journals covering a range of subjects launched their inaugural issues in June 2025. We are excited to be able to share with you the newest research rooted in the value of open access. We are pleased to present the latest research and to make it accessible to all.

We extend our sincere thanks to all the Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Chang-Pu Sun, China Academy of Engineering Physics, Beijing, China; Computational Science Research Center, China Editorial | View inaugural issue	quantum information and phenomena; condensed matter physics and statistical physics; atomic, molecular, and optical physics; computational physics and mathematical methods View journal scope | Submit an article
	Prof. Dr. Hualiang Lin, Sun Yat-sen University, China; Prof. Dr. Jose L. Domingo, Universitat Rovira i Virgili, Spain Editorial | View inaugural issue	green and organic food; green infrastructures; green exercise; environmental impact of the healthcare sector; effects of climate change on human health | View journal scope | Submit an article
	Prof. Dr. Francesco Veglio, University of L’Aquila, Italy Editorial | View inaugural issue	ultra-pure substances; water purification; air purification; gas purification; inorganic chemical purification; purification technologies View journal scope | Submit an article
	Prof. Dr. Junxing Zheng, Huazhong University of Science and Technology, China Editorial | View inaugural issue	computer-aided design and engineering; artificial intelligence and machine learning; building information modeling (BIM) and digital twins; robotics and automation in construction; smart sensors and Internet of Things (IoT); intelligent control systems and facilities management View journal scope | Submit an article
	Prof. Dr. Assunta Di Vaio, University of Naples Parthenope, Italy Editorial | View inaugural issue	sustainability, managerial, and biodiversity accounting; carbon management accounting; corporate social responsibility; artificial intelligence and disclosure View journal scope | Submit an article
	Prof. Dr. Changjun Liu, Sichuan University, China Editorial | View inaugural issue	bioeffects of electromagnetic waves; electromagnetic science and engineering; microwave, millimeter-wave, and terahertz technologies; metamaterials and metasurfaces; communication, sensing, and networks; energy, power, and sustainable applications; quantum and emerging technologies; artificial intelligence and advanced fabrication View journal scope | Submit an article

The “Cell Biology and Pathology” Section covers all aspects of this general field, from molecular machines that enable or adversely modify cell function to the pathology of complete organisms. Both review articles and original research contributions are welcome, as long as they conform to the highest scientific standards. Contributions that explore the origin of diseases at the molecular level, such as structural, biochemical, and genetic studies of receptors, oncogenes, tumor suppressors and regulatory proteins, signal pathways, and RNA/DNA, as well as articles that propose new routes for the cure and prevention of diseases, are of particular interest. Cutting-edge diagnostic tools ranging from PCR to magnetic resonance, as applied to the detection of cellular or organismic pathological dysfunctions on all levels, will be accepted. In this context, we are pleased to feature some recently published papers from the “Cell Biology and Pathology” Section in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.

1. “Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review”
by Alexandra-Ioana Dănilă, Laura Andreea Ghenciu, Emil Robert Stoicescu, Sorin Lucian Bolintineanu, Roxana Iacob, Mihai-Alexandru Săndesc and Alexandra Corina Faur
Biomedicines 2024, 12(4), 747; https://doi.org/10.3390/biomedicines12040747
Available online: https://www.mdpi.com/2227-9059/12/4/747

2. “The Role of Fibroblasts in Skin Homeostasis and Repair”
by Federica Boraldi, Francesco Demetrio Lofaro, Susanna Bonacorsi, Alessia Mazzilli, Maria Garcia-Fernandez and Daniela Quaglino
Biomedicines 2024, 12(7), 1586; https://doi.org/10.3390/biomedicines12071586
Available online: https://www.mdpi.com/2227-9059/12/7/1586

3. “Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine”
by Ramcharan Singh Angom and Naga Malleswara Rao Nakka
Biomedicines 2024, 12(3), 693; https://doi.org/10.3390/biomedicines12030693
Available online: https://www.mdpi.com/2227-9059/12/3/693

4. “Is Chronic Kidney Disease Due to Cadmium Exposure Inevitable and Can It Be Reversed?”
by Soisungwan Satarug
Biomedicines 2024, 12(4), 718; https://doi.org/10.3390/biomedicines12040718
Available online: https://www.mdpi.com/2227-9059/12/4/718

5. “Roles of Macrophages and Endothelial Cells and Their Crosstalk in Acute Lung Injury”
by Sara Osorio-Valencia and Bisheng Zhou
Biomedicines 2024, 12(3), 632; https://doi.org/10.3390/biomedicines12030632
Available online: https://www.mdpi.com/2227-9059/12/3/632

6. “UCP2, a Member of the Mitochondrial Uncoupling Proteins: An Overview from Physiological to Pathological Roles”
by Salvatore Nesci and Speranza Rubattu
Biomedicines 2024, 12(6), 1307; https://doi.org/10.3390/biomedicines12061307
Available online: https://www.mdpi.com/2227-9059/12/6/1307

7. “Latest Advances in Chondrocyte-Based Cartilage Repair”
by Li Yue, Ryan Lim and Brett D. Owens
Biomedicines 2024, 12(6), 1367; https://doi.org/10.3390/biomedicines12061367
Available online: https://www.mdpi.com/2227-9059/12/6/1367

8. “Understanding Tendon Fibroblast Biology and Heterogeneity”
by Sarah E. DiIorio, Bill Young, Jennifer B. Parker, Michelle F. Griffin and Michael T. Longaker
Biomedicines 2024, 12(4), 859; https://doi.org/10.3390/biomedicines12040859
Available online: https://www.mdpi.com/2227-9059/12/4/859

9. “Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting”
by Dario Troise, Barbara Infante, Silvia Mercuri, Valeria Catalano, Elena Ranieri and Giovanni Stallone
Biomedicines 2024, 12(6), 1240; https://doi.org/10.3390/biomedicines12061240
Available online: https://www.mdpi.com/2227-9059/12/6/1240

10. “Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence”
by Camille Laliberté, Bianca Bossé, Véronique Bourdeau, Luis I. Prieto, Genève Perron-Deshaies, Nhung Vuong-Robillard, Sebastian Igelmann, Lisbeth Carolina Aguilar, Marlene Oeffinger, Darren J. Baker et al.
Biomedicines 2024, 12(5), 1089; https://doi.org/10.3390/biomedicines12051089
Available online: https://www.mdpi.com/2227-9059/12/5/1089

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link:
https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The “Immunology and Immunotherapy” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of immunology and oncoimmunology. Papers aim to uncover modulations in the immune system, active and passive immunotherapies, diagnostic tests based on specific markers, and new technologies to identify novel predictive factors to respond to immunotherapy. Topics include but are not limited to in vivo/in vitro immune response research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.

1. “Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator”
by Mostafa Hamada, Kyle Steven Varkoly, Omer Riyadh, Roxana Beladi, Ganesh Munuswamy-Ramanujam, Alan Rawls, Jeanne Wilson-Rawls, Hao Chen, Grant McFadden and Alexandra R. Lucas
Biomedicines 2024, 12(6), 1167; https://doi.org/10.3390/biomedicines12061167
Available online: https://www.mdpi.com/2227-9059/12/6/1167

2. “Pathogenesis, Prophylaxis, and Treatment of Candida auris”
by Madalina Preda, Razvan Daniel Chivu, Lia Mara Ditu, Oana Popescu and Loredana Sabina Cornelia Manolescu
Biomedicines 2024, 12(3), 561; https://doi.org/10.3390/biomedicines12030561
Available online: https://www.mdpi.com/2227-9059/12/3/561

3. “Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane”
by Solomon Habtemariam
Biomedicines 2024, 12(6), 1169; https://doi.org/10.3390/biomedicines12061169
Available online: https://www.mdpi.com/2227-9059/12/6/1169

4. “Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation”
by Mary Garvey
Biomedicines 2024, 12(4), 740; https://doi.org/10.3390/biomedicines12040740
Available online: https://www.mdpi.com/2227-9059/12/4/740

5. “The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases”
by Carmela Coccia, Francesco Bonomi, Anna Lo Cricchio, Edda Russo, Silvia Peretti, Giulia Bandini, Gemma Lepri, Francesca Bartoli, Alberto Moggi-Pignone, Serena Guiducci et al.
Biomedicines 2024, 12(8), 1760; https://doi.org/10.3390/biomedicines12081760
Available online: https://www.mdpi.com/2227-9059/12/8/1760

6. “The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury”
by Gillene Santos Ferreira, Melissa Lopes Frota, Maria José Dias Gonzaga, Maria de Fátima Fernandes Vattimo and Camila Lima
Biomedicines 2024, 12(5), 931; https://doi.org/10.3390/biomedicines12050931
Available online: https://www.mdpi.com/2227-9059/12/5/931

7. “Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases”
by Chieh-Yu Shen, Cheng-Hsun Lu, Chiao-Feng Cheng, Ko-Jen Li, Yu-Min Kuo, Cheng-Han Wu, Chin-Hsiu Liu, Song-Chou Hsieh, Chang-Youh Tsai and Chia-Li Yu
Biomedicines 2024, 12(8), 1699; https://doi.org/10.3390/biomedicines12081699
Available online: https://www.mdpi.com/2227-9059/12/8/1699

8. “Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective”
by Marco Caminati, Matteo Maule, Roberto Benoni, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Luisa Brussino, Paolo Cameli, Maria Giulia Candeliere, Giovanna Elisiana Carpagnano et al.
Biomedicines 2024, 12(2), 390; https://doi.org/10.3390/biomedicines12020390
Available online: https://www.mdpi.com/2227-9059/12/2/390

9. “Unraveling the Link between Insulin Resistance and Bronchial Asthma”
by Konstantinos Bartziokas, Andriana I. Papaioannou, Fotios Drakopanagiotakis, Evanthia Gouveri, Nikolaos Papanas and Paschalis Steiropoulos
Biomedicines 2024, 12(2), 437; https://doi.org/10.3390/biomedicines12020437
Available online: https://www.mdpi.com/2227-9059/12/2/437

10. “Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases”
by Katarzyna Antosz, Joanna Batko, Marta Błażejewska, Antoni Gawor, Jakub Sleziak and Krzysztof Gomułka
Biomedicines 2024, 12(7), 1531; https://doi.org/10.3390/biomedicines12071531
Available online: https://www.mdpi.com/2227-9059/12/7/1531

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link:
https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The “Molecular and Translational Medicine” Section publishes reviews and original peer-reviewed papers which aim to cover studies concerning disease pathogenesis at the molecular or physiological level, as well as basic preclinical, clinical, and translational aspects. We encourage scientists to submit their results that have the potential for application in human disease, as well as research obtained from clinical trials or animal models of human diseases that has the potential to shed light on the underlying causes of various human diseases and cancer, allowing for the development of future human medicines, medical devices, and diagnostics. In this context, we are pleased to feature some recently published papers on molecular and translational medicine in Biomedicines (ISSN: 2227-9059), which will provide valuable insights into this exciting field.

1. “Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare”
by Alex E. Mohr, Carmen P. Ortega-Santos, Corrie M. Whisner, Judith Klein-Seetharaman and Paniz Jasbi
Biomedicines 2024, 12(7), 1496; https://doi.org/10.3390/biomedicines12071496
Available online: https://www.mdpi.com/2227-9059/12/7/1496

2. “Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers”
by Giancarlo Trimarchi, Lucio Teresi, Roberto Licordari, Alessandro Pingitore, Fausto Pizzino, Patrizia Grimaldi, Danila Calabrò, Paolo Liotta, Antonio Micari, Cesare de Gregorio et al
Biomedicine. 2024, 12(5), 1051; https://doi.org/10.3390/biomedicines12051051
Available online: https://www.mdpi.com/2227-9059/12/5/1051

3. “Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies”
by Lina Noelia Jurado-Priego, Cristina Cueto-Ureña, María Jesús Ramírez-Expósito and José Manuel Martínez-Martos
Biomedicines 2024, 12(7), 1543; https://doi.org/10.3390/biomedicines12071543
Available online: https://www.mdpi.com/2227-9059/12/7/1543

4. “Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions”
by Rajesh Jha, Sara Lopez-Trevino, Haritha R. Kankanamalage and Jay C. Jha
Biomedicines 2024, 12(5), 1098. https://doi.org/10.3390/biomedicines12051098
Available online: https://www.mdpi.com/2227-9059/12/5/1098

5. “Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators”
by Cristina M. Padovani and Kingsley Yin
Biomedicines 2024, 12(1), 175. https://doi.org/10.3390/biomedicines12010175
Available online: https://www.mdpi.com/2227-9059/12/1/175

6. “Osteoporosis, Osteoarthritis, and Subchondral Insufficiency Fracture: Recent Insights”
by Shunichi Yokota, Hotaka Ishizu, Takuji Miyazaki, Daisuke Takahashi, Norimasa Iwasaki and Tomohiro Shimizu
Biomedicines 2024, 12(4), 843; https://doi.org/10.3390/biomedicines12040843
Available online: https://www.mdpi.com/2227-9059/12/4/843

7. “Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline”
by Antonio Lardaro, Ludovica Quarta, Stefania Pagnotta, Giorgio Sodero, Sandro Mariani, Maria Del Ben, Giovambattista Desideri, Evaristo Ettorre and Francesco Baratta
Biomedicines 2024, 12(8),1750; https://doi.org/10.3390/biomedicines12081750
Available online: https://www.mdpi.com/2227-9059/12/8/1750

8. “Current Knowledge on the Use of Neuromonitoring in Thyroid Surgery”
by Beata Wojtczak, Karolina Sutkowska-Stępień, Mateusz Głód, Krzysztof Kaliszewski, Krzysztof Sutkowski and Marcin Barczyński
Biomedicines 2024, 12(3), 675; https://doi.org/10.3390/biomedicines12030675
Available online: https://www.mdpi.com/2227-9059/12/3/675

9. “Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer’s Disease”
by Sergei M. Danilov, Ivan A. Adzhubei, Alexander J. Kozuch, Pavel A. Petukhov, Isolda A. Popova, Ananyo Choudhury, Dhriti Sengupta and Steven M. Dudek
Biomedicines 2024, 12(1), 162; https://doi.org/10.3390/biomedicines12010162
Available online: https://www.mdpi.com/2227-9059/12/1/162

10. “Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?”
by Mohammad Jad Moussa, Matthew T. Campbell and Omar Alhalabi
Biomedicines 2024, 12(3), 519; https://doi.org/10.3390/biomedicines12030519
Available online: https://www.mdpi.com/2227-9059/12/3/519

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines. 

Joining the Volunteer Reviewer Board:
If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit. 

Biomedicines Editorial Office

The “Gene and Cell Therapy” Section publishes reviews and original peer-reviewed papers. This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage submissions of manuscripts that provide novel and mechanistic insights, including but not limited to gene transfer; vector development and design; autologous and allogeneic cell therapies (hematopoietic and mesenchymal stem cell therapies); the development of genes, peptides, proteins, oligonucleotides, and cell therapies to correct genetic and acquired diseases; vaccine development; preclinical target validation; and other research aspects. In this context, we are pleased to feature some recently published papers from the “Gene and Cell Therapy” Section in Biomedicines (ISSN: 2227-9059), which will provide valuable insights into this exciting field.

1. “Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma”
by Alessandro Allegra, Giuseppe Murdaca, Giuseppe Mirabile and Sebastiano Gangemi
Biomedicines 2024, 12(3), 514; https://doi.org/10.3390/biomedicines12030514
Available online: https://www.mdpi.com/2227-9059/12/3/514

2. “MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study”
by Davida Mirra, Renata Esposito, Giuseppe Spaziano, Liberata Sportiello, Francesca Panico, Antonio Squillante, Maddalena Falciani, Ida Cerqua , Luca Gallelli, Erika Cione and Bruno D’Agostino
Biomedicines 2024, 12(5), 1050; https://doi.org/10.3390/biomedicines12051050
Available online: https://www.mdpi.com/2227-9059/12/5/1050

3. “Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome”
by Remi Sumiyoshi, Tomohiro Koga and Atsushi Kawakami
Biomedicines 2024, 12(6), 1141; https://doi.org/10.3390/biomedicines12061141
Available online: https://www.mdpi.com/2227-9059/12/6/1141

4. “Structural Changes Likely Cause Chemical Differences between Empty and Full AAV Capsids”
by Caryn L. Heldt, Molly A. Skinner and Ganesh S. Anand
Biomedicines 2024, 12(9), 2128; https://doi.org/10.3390/biomedicines12092128
Available online: https://www.mdpi.com/2227-9059/12/9/2128

5. “Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer”
by Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan, Robert Pompa, David Kwon and Shyam Nyati
Biomedicines 2024, 12(5), 1065; https://doi.org/10.3390/biomedicines12051065
Available online: https://www.mdpi.com/2227-9059/12/5/1065

6. “Potential Causal Association between C-Reactive Protein Levels in Age-Related Macular Degeneration: A Two-Sample Mendelian Randomization Study”
by Byung Woo Yoon, Young Lee and Je Hyun Seo
Biomedicines 2024, 12(4), 807; https://doi.org/10.3390/biomedicines12040807
Available online: https://www.mdpi.com/2227-9059/12/4/807

7. “A Comprehensive Exploration of Therapeutic Strategies in Inflammatory Bowel Diseases: Insights from Human and Animal Studies”
by Inês Esteves Dias, Isabel Ribeiro Dias, Teresa Franchi-Mendes, Carlos Antunes Viegas and Pedro Pires Carvalho
Biomedicines 2024, 12(4), 735; https://doi.org/10.3390/biomedicines12040735
Available online: https://www.mdpi.com/2227-9059/12/4/735

8. “Regenerative Therapy for Corneal Scarring Disorders”
by Christine Chandran, Mithun Santra, Elizabeth Rubin, Moira L. Geary and Gary Hin-Fai Yam
Biomedicines 2024, 12(3), 649; https://doi.org/10.3390/biomedicines12030649
Available online: https://www.mdpi.com/2227-9059/12/3/649

9. “Application of SWATH Mass Spectrometry and Machine Learning in the Diagnosis of Inflammatory Bowel Disease Based on the Stool Proteome”
by Elmira Shajari, David Gagné, Mandy Malick, Patricia Roy, Jean-François Noël, Hugo Gagnon, Marie A. Brunet, Maxime Delisle, François-Michel Boisvert and Jean-François Beaulieu
Biomedicines 2024, 12(2), 333; https://doi.org/10.3390/biomedicines12020333
Available online: https://www.mdpi.com/2227-9059/12/2/333

10. “CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo”
by Eunhee Park, Hui-jin Mun, Eunju Seo, Seojin Hwang, Jae Hee Lee, Sukgil Song, Hyeran Sung, Hoi-Yul Kim and Mi-Jin Kwon
Biomedicines 2024, 12(1), 248; https://doi.org/10.3390/biomedicines12010248
Available online: https://www.mdpi.com/2227-9059/12/1/248

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:

This Section is currently open for submissions. Papers may be submitted via the following link:

https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:

If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The Section “Molecular Genetics and Genetic Diseases” covers the basic and translational aspects of human genetic diseases and genomics research, from fundamental molecular investigation to preclinical animal models. In particular, this Section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the treatment of genetic disorders and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics and bioinformatic tools to advance knowledge in human genetic diseases.

1. “Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future”
by Mohammed Tiseer Abbas, Nima Baba Ali, Juan M. Farina, Ahmed K. Mahmoud, Milagros Pereyra, Isabel G. Scalia, Moaz A. Kamel, Timothy Barry, Steven J. Lester, Charles R. Cannan et al.
Biomedicines 2024, 12(3), 682; https://doi.org/10.3390/biomedicines12030682
Available online: https://www.mdpi.com/2227-9059/12/3/682#

2. “Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS)”
by John A. D’Elia and Larry A. Weinrauch
Biomedicines 2024, 12(5), 978; https://doi.org/10.3390/biomedicines12050978
Available online: https://www.mdpi.com/2227-9059/12/5/978

3. “Predictors of Successful Testicular Sperm Extraction: A New Era for Men with Non-Obstructive Azoospermia”
by Aris Kaltsas, Sofoklis Stavros, Zisis Kratiras, Athanasios Zikopoulos, Nikolaos Machairiotis, Anastasios Potiris, Fotios Dimitriadis, Nikolaos Sofikitis, Michael Chrisofos and Athanasios Zachariou
Biomedicines 2024, 12(12), 2679; https://doi.org/10.3390/biomedicines12122679
Available online: https://www.mdpi.com/2227-9059/12/12/2679

4. “Burning Mouth Syndrome Treated with Low-Level Laser and Clonazepam: A Randomized, Single-Blind Clinical Trial”
by Ana Garcia Martinez, Pia Lopez-Jornet, Luis Pardo Marin, Eduardo Pons-Fuster and Asta Tvarijonaviciute
Biomedicines 2024, 12(5), 1048; https://doi.org/10.3390/biomedicines12051048
Available online: https://www.mdpi.com/2227-9059/12/5/1048

5. “Physiological Consequences of Nonsense-Mediated Decay and Its Role in Adaptive Responses”
by Zhengxin Ma, Ratna Sharma and Aric N. Rogers
Biomedicines 2024, 12(5), 1110; https://doi.org/10.3390/biomedicines12051110
Available online: https://www.mdpi.com/2227-9059/12/5/1110

6. “Sarcoidosis Associated Pulmonary Hypertension”
by Alexander Liu, Laura C. Price, Rakesh Sharma, Athol U. Wells and Vasileios Kouranos
Biomedicines 2024, 12(1), 177; https://doi.org/10.3390/biomedicines12010177
Available online: https://www.mdpi.com/2227-9059/12/1/177

7. “Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability”
by Ewud Agborbesong, Julie Xia Zhou, Hongbing Zhang, Linda Xiaoyan Li, Peter C. Harris, James P. Calvet and Xiaogang Li
Biomedicines 2024, 12(3), 603; https://doi.org/10.3390/biomedicines12030603
Available online: https://www.mdpi.com/2227-9059/12/3/603

8. “Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update”
by Iulia Lupan, Vasile Bintintan, Diana Deleanu and Gabriel Samasca
Biomedicines 2024, 12(9), 2001; https://doi.org/10.3390/biomedicines12092001
Available online: https://www.mdpi.com/2227-9059/12/9/2001

9. “The Influence of Tacrolimus Exposure and Metabolism on the Outcomes of Kidney Transplants”
by Rima Maslauskiene, Ruta Vaiciuniene, Aurelija Radzeviciene, Peteris Tretjakovs, Gita Gersone, Edgaras Stankevicius and Inga Arune Bumblyte
Biomedicines 2024, 12(5), 1125; https://doi.org/10.3390/biomedicines12051125
Available online: https://www.mdpi.com/2227-9059/12/5/1125

10. “Current Immunotherapy Treatments of Primary Breast Cancer Subtypes”
by Savannah R. Brown and Emilie E. Vomhof-DeKrey
Biomedicines 2024, 12(4), 895; https://doi.org/10.3390/biomedicines12040895
Available online: https://www.mdpi.com/2227-9059/12/4/895

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link:
https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The “Nanomedicine and Nanobiology” Section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of nanomedicine. Papers aim to uncover the synthesis, bioavailability, and biodistribution of nanomedicines; the delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms. In this context, we are pleased to feature some recently published papers from the “Nanomedicine and Nanobiology” Section in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.

1. “An In Vitro Model to Assess Early Immune Markers Following Co-Exposure of Epithelial Cells to Carbon Black (Nano)Particles in the Presence of S. aureus: A Role for Stressed Cells in Toxicological Testing”
by Scott Brown, Stephen J. Evans, Michael J. Burgum, Kirsty Meldrum, Jack Herridge, Blessing Akinbola, Llinos G. Harris, Rowena Jenkins, Shareen H. Doak, Martin J. D. Clift et al.
Biomedicines 2024, 12(1), 128; https://doi.org/10.3390/biomedicines12010128
Available online: https://www.mdpi.com/2227-9059/12/1/128

2. “Innovative Biomedical and Technological Strategies for the Control of Bacterial Growth and Infections”
by Lídia Leonize Rodrigues Matias, Karla Suzanne Florentino da Silva Chaves Damasceno, Annemberg Salvino Pereira, Thaís Souza Passos and Ana Heloneida de Araujo Morais
Biomedicines 2024, 12(1), 176; https://doi.org/10.3390/biomedicines12010176
Available online: https://www.mdpi.com/2227-9059/12/1/176

3. “Nanotechnology Innovations in Pediatric Cardiology and Cardiovascular Medicine: A Comprehensive Review”
by Stefana Maria Moisa, Alexandru Burlacu, Lacramioara Ionela Butnariu, Corina Maria Vasile, Crischentian Brinza, Elena Lia Spoiala, Alexandra Maștaleru, Maria Magdalena Leon, Solange Tamara Rosu, Radu Vatasescu et al.
Biomedicines 2024, 12(1), 185; https://doi.org/10.3390/biomedicines12010185
Available online: https://www.mdpi.com/2227-9059/12/1/185

4. “Biological Effects of Small Sized Graphene Oxide Nanosheets on Human Leukocytes”
by Michele Aventaggiato, Federica Valentini, Daniela Caissutti, Michela Relucenti, Marco Tafani, Roberta Misasi, Alessandra Zicari, Sara Di Martino, Sara Virtuoso, Anna Neri et al.
Biomedicines 2024, 12(2), 256; https://doi.org/10.3390/biomedicines12020256
Available online: https://www.mdpi.com/2227-9059/12/2/256

5. “Advancing Cancer Treatment: Enhanced Combination Therapy through Functionalized Porous Nanoparticles”
by Kibeom Kim and Myoung-Hwan Park
Biomedicines 2024, 12(2), 326; https://doi.org/10.3390/biomedicines12020326
Available online: https://www.mdpi.com/2227-9059/12/2/326

6. “Nanomaterials Based on 2,7,12,17-Tetra-tert-butyl-5,10,15,20-tetraaza-21H,23H-porphine Exhibiting Bifunctional Sensitivity for Monitoring Chloramphenicol and Co²⁺”
by Ionela Fringu, Diana Anghel, Ion Fratilescu, Camelia Epuran, Mihaela Birdeanu and Eugenia Fagadar-Cosma
Biomedicines 2024, 12(4), 770; https://doi.org/10.3390/biomedicines12040770
Available online: https://www.mdpi.com/2227-9059/12/4/770

7. “Sinus Floor Augmentation with Synthetic Hydroxyapatite (NanoBone®) in Combination with Platelet-Rich Fibrin: A Case Series”
by Luís Francisco, Manuel Francisco, Rosana Costa, Miguel Nunes Vasques, Marta Relvas, António Rajão, Luís Monteiro, Paulo Rompante, Fernando Guerra and Marco Infante da Câmara
Biomedicines 2024, 12(8), 1661; https://doi.org/10.3390/biomedicines12081661
Available online: https://www.mdpi.com/2227-9059/12/8/1661

8. “Toxicological Assessment of Biodegradable Poli-ε-Caprolactone Polymer Composite Materials Containing Hydroxyapatite, Bioglass, and Chitosan as Potential Biomaterials for Bone Regeneration Scaffolds”
by Aleksandra Skubis-Sikora, Andrzej Hudecki, Bartosz Sikora, Patrycja Wieczorek, Mateusz Hermyt, Marek Hreczka, Wirginia Likus, Jarosław Markowski, Krzysztof Siemianowicz, Aleksandra Kolano-Burian et al.
Biomedicines 2024, 12(9), 1949; https://doi.org/10.3390/biomedicines12091949
Available online: https://www.mdpi.com/2227-9059/12/9/1949

9. “A General Method to Screen Nanobodies for Cytochrome P450 Enzymes from a Yeast Surface Display Library”
by Yudong Sun, Cristian Martinez-Ramos, Eugene Chen, Yoichi Osawa and Haoming Zhang
Biomedicines 2024, 12(8), 1863; https://doi.org/10.3390/biomedicines12081863
Available online: https://www.mdpi.com/2227-9059/12/8/1863

10. “Multifractal Analysis and Experimental Evaluation of MCM-48 Mesoporous Silica as a Drug Delivery System for Metformin Hydrochloride”
by Mousa Sha’at, Maria Ignat, Liviu Sacarescu, Adrian Florin Spac, Alexandra Barsan (Bujor), Vlad Ghizdovat, Emanuel Nazaretian, Catalin Dumitras, Maricel Agop, Cristina Marcela Rusu et al.
Biomedicines 2024, 12(12), 2838; https://doi.org/10.3390/biomedicines12122838
Available online: https://www.mdpi.com/2227-9059/12/12/2838

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:

This Section is currently open for submissions. Papers may be submitted via the following link:

https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:

If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The “Drug Discovery, Development and Delivery” Section publishes original and innovative scientific papers, as well as comprehensive review papers. In this context, we are pleased to feature some recently published papers in Biomedicines (ISSN: 2227-9059) on drug discovery, drug design, basic and clinical pharmacology, formulation and delivery, and toxicology, which will provide valuable insights into this exciting field.

1. “Aptamer-Based Smart Targeting and Spatial Trigger–Response Drug-Delivery Systems for Anticancer Therapy”
by Dongsik Park, Su Jin Lee and Jee-Woong Park
Biomedicines 2024, 12(1), 187; https://doi.org/10.3390/biomedicines12010187
Available online: https://www.mdpi.com/2227-9059/12/1/187

2. “The Use of Nigella sativa in Cardiometabolic Diseases”
by Giuseppe Derosa, Angela D’Angelo, Pamela Maffioli, Laura Cucinella and Rossella Elena Nappi
Biomedicines 2024, 12(2), 405; https://doi.org/10.3390/biomedicines12020405
Available online: https://www.mdpi.com/2227-9059/12/2/405

3. “Safety Profile of the Trastuzumab-Based ADCs: Analysis of Real-World Data Registered in EudraVigilance”
by Claudiu Morgovan, Carmen Maximiliana Dobrea, Anca Butuca, Anca Maria Arseniu, Adina Frum, Luca Liviu Rus, Adriana Aurelia Chis, Anca Maria Juncan, Felicia Gabriela Gligor, Cecilia Georgescu et al.
Biomedicines 2024, 12(5), 953; https://doi.org/10.3390/biomedicines12050953
Available online: https://www.mdpi.com/2227-9059/12/5/953

4. “Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine”
by Francesco Gervasi and Fanny Pojero
Biomedicines 2024, 12(3), 502; https://doi.org/10.3390/biomedicines12030502
Available online: https://www.mdpi.com/2227-9059/12/3/502

5. “Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes”
by Matteo Nardin, Monica Verdoia, Simone Nardin, Davide Cao, Mauro Chiarito, Elvin Kedhi, Gennaro Galasso, Gianluigi Condorelli and Giuseppe De Luca
Biomedicines 2024, 12(4), 768; https://doi.org/10.3390/biomedicines12040768
Available online: https://www.mdpi.com/2227-9059/12/4/768

6. “Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects”
by Żaneta Słyk, Natalia Stachowiak and Maciej Małecki
Biomedicines 2024, 12(7), 1523; https://doi.org/10.3390/biomedicines12071523
Available online: https://www.mdpi.com/2227-9059/12/7/1523

7. “Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines”
by Nanami Irie, Kana Mizoguchi, Tomoko Warita, Mirai Nakano, Kasuga Sasaki, Jiro Tashiro, Tomohiro Osaki, Takuro Ishikawa, Zoltán N. Oltvai and Katsuhiko Warita
Biomedicines 2024, 12(3), 698; https://doi.org/10.3390/biomedicines12030698
Available online: https://www.mdpi.com/2227-9059/12/3/698

8. “Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy”
by Kibeom Kim and Myoung-Hwan Park
Biomedicines 2024, 12(1), 202; https://doi.org/10.3390/biomedicines12010202
Available online: https://www.mdpi.com/2227-9059/12/1/202

9. “Conjecturing about Small-Molecule Agonists and Antagonists of α4β1 Integrin: From Mechanistic Insight to Potential Therapeutic Applications”
by Tingting He, Daria Giacomini, Alessandra Tolomelli, Monica Baiula and Luca Gentilucci
Biomedicines 2024, 12(2), 316; https://doi.org/10.3390/biomedicines12020316
Available online: https://www.mdpi.com/2227-9059/12/2/316

10. “Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center”
by Jasmin Abu Arif, Vitus André Knecht, Anne Rübsam, Vanessa Lussac, Zohreh Jami, Dominika Pohlmann, Bert Müller and Uwe Pleyer
Biomedicines 2024, 12(5), 1106; https://doi.org/10.3390/biomedicines12051106
Available online: https://www.mdpi.com/2227-9059/12/5/1106

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office

The “Cancer Biology and Oncology” Section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance and a better understanding of the interrelations between cancer and metabolism in addition to a better understanding of the tumor and its microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such as those involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.

1. “Dysbiosis Signature of Fecal Microbiota in Patients with Pancreatic Adenocarcinoma and Pancreatic Intraductal Papillary Mucinous Neoplasms”
by Theodoros Sidiropoulos, Nikolas Dovrolis, Hector Katifelis, Nikolaos V. Michalopoulos, Panagiotis Kokoropoulos, Nikolaos Arkadopoulos and Maria Gazouli
Biomedicines 2024, 12(5), 1040; https://doi.org/10.3390/biomedicines12051040
Available online: https://www.mdpi.com/2227-9059/12/5/1040

2. “IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia”
by Jonathan Paolino, Harrison K. Tsai, Marian H. Harris and Yana Pikman
Biomedicines 2024, 12(1), 89; https://doi.org/10.3390/biomedicines12010089
Available online: https://www.mdpi.com/2227-9059/12/1/89

3. “miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression”
by Francesca Maria Orlandella, Esther Imperlini, Katia Pane, Neila Luciano, Mariantonia Braile, Anna Elisa De Stefano, Paola Lucia Chiara Iervolino, Alessandro Ruocco, Stefania Orrù, Monica Franzese et al.
Biomedicines 2024, 12(3), 658. https://doi.org/10.3390/biomedicines12030658
Available online: https://www.mdpi.com/2227-9059/12/3/658

4. “Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer”
by Hänel W. Eberly, Bao Y. Sciscent, F. Jeffrey Lorenz, Eleni M. Rettig and Neerav Goyal
Biomedicines 2024, 12(2), 415; https://doi.org/10.3390/biomedicines12020415
Available online: https://www.mdpi.com/2227-9059/12/2/415

5. “Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes”
by Aleksandra Ciarka, Michał Piątek, Rafał Pęksa, Michał Kunc and Elżbieta Senkus
Biomedicines 2024, 12(4), 763; https://doi.org/10.3390/biomedicines12040763
Available online: https://www.mdpi.com/2227-9059/12/4/763

6. “Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging”
by Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen and Jean-Luc Van Laethem
Biomedicines 2024, 12(3), 591; https://doi.org/10.3390/biomedicines12030591
Available online: https://www.mdpi.com/2227-9059/12/3/591

7. “Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification”
by Tomohiro Chiba
Biomedicines 2024, 12(4), 712; https://doi.org/10.3390/biomedicines12040712
Available online: https://www.mdpi.com/2227-9059/12/4/712

8. “Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer”
by Giuseppe Saltalamacchia, Rosalba Torrisi, Rita De Sanctis, Giovanna Masci, Chiara Miggiano, Mariangela Gaudio, Chiara Benvenuti, Flavia Jacobs, Riccardo Gerosa, Armando Santoro et al.
Biomedicines 2024, 12(3), 500; https://doi.org/10.3390/biomedicines12030500
Available online: https://www.mdpi.com/2227-9059/12/3/500

9. “Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer”
by David K. Lau, Jack P. Collin and John M. Mariadason
Biomedicines 2024, 12(5), 1117; https://doi.org/10.3390/biomedicines12051117
Available online: https://www.mdpi.com/2227-9059/12/5/1117

10. “Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment”
by Agata M.Gawel, Anna Betkowska, Ewa Gajda, Marlena Godlewska and Damian Gawel
Biomedicines 2024, 12(8), 1822; https://doi.org/10.3390/biomedicines12081822
Available online: https://www.mdpi.com/2227-9059/12/8/1822

To acknowledge the above authors’ excellent contributions, we are happy to provide a full waiver to each team of the above publications. We also would like to take this opportunity to thank all the research groups that have submitted to Biomedicines (ISSN: 2227-9059). We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest to you:

Submitting a manuscript:

This Section is currently open for submissions. Papers may be submitted via the following link:

https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:

If you are an active researcher in the field of biomedicinal research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office